Senior Director, Business Development-Data & AI Oncology

Natera is the global leader in the development of blood-based diagnostics and has built considerable momentum in the utilization of our Signatera (tumor informed) and Latitude (tumor naïve) assays.  Year 2025 reflected a significant increase in the utilization of Signatera with >700k samples processed across our labs.  Our WGS/WES repertoire and the integration of Foresight’s phased variants technique and expertise in Lymphomas has enabled Natera to offer the mo